65322-98-7 Usage
Uses
Used in Pharmaceutical Industry:
Carbapenem MM22383 is used as an antibiotic for the treatment of various bacterial infections, including those caused by gram-negative and gram-positive bacteria. Its broad-spectrum activity and ability to penetrate bacterial cell walls make it an effective treatment option for a wide range of infections.
Used in Hospital Settings:
In hospitals, carbapenem MM22383 is used as a last-resort antibiotic for treating severe and drug-resistant bacterial infections. Its effectiveness against a wide range of bacteria, including those that are resistant to other antibiotics, makes it a valuable tool in the management of complex and life-threatening infections.
Used in Research and Development:
Carbapenem MM22383 is also used in research and development for the study of antibiotic resistance, bacterial cell wall structure, and the development of new antimicrobial agents. Its unique properties and broad-spectrum activity make it a valuable compound for understanding the mechanisms of bacterial resistance and the design of new drugs to combat resistant infections.
Check Digit Verification of cas no
The CAS Registry Mumber 65322-98-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,3,2 and 2 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 65322-98:
(7*6)+(6*5)+(5*3)+(4*2)+(3*2)+(2*9)+(1*8)=127
127 % 10 = 7
So 65322-98-7 is a valid CAS Registry Number.
65322-98-7Relevant academic research and scientific papers
Total Synthesis of (+/-)-Epithienamycins A and B and Derivatives
Kametani, Tetsuji,Huang, Shyh-Pyng,Nagahara, Takayasu,Ihara, Masataka
, p. 2282 - 2286 (2007/10/02)
(+/-)-(3R*,4R*)-4-(2,2-Dimethoxyethyl)-3-*)-1-hydroxyethyl>azetidin-2-one (7), which has been stereoselectively synthesised via the 4-methoxycarbonylisoxazoline (4), was converted into (+/-)-epithienamycins A (2) and B
TOTAL SYNTHESIS OF (+/-)EPITHIENAMYCINS A AND B
Kametani, Tetsuji,Huang, Shyh-Pyng,Nagahara, Takayasu,Ihara, Masataka
, p. 65 - 70 (2007/10/02)
(+/-)-3R*-(1'S*-Hydroxyethyl)-4R*-(2',2'-dimethoxyethyl)-2-azetidinone (6), which was obtained from the 4-methoxycarbonylisoxazoline (4) as a major product, was converted into (+/-)-epithienamycins A(2) and B(3) vi
